See more : GSK plc (GSK) Income Statement Analysis – Financial Results
Complete financial analysis of WOWI, Inc. (WOWU) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of WOWI, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Nihon Seimitsu Co., Ltd. (7771.T) Income Statement Analysis – Financial Results
- HATCH WORK CO. LTD (148A.T) Income Statement Analysis – Financial Results
- LeanLife Health Inc. (LLP.CN) Income Statement Analysis – Financial Results
- BerGenBio ASA (BGBIO.OL) Income Statement Analysis – Financial Results
- HiVi Acoustics Technology Co., Ltd (002888.SZ) Income Statement Analysis – Financial Results
WOWI, Inc. (WOWU)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://worldofweedinc.com
About WOWI, Inc.
WOWI, Inc., an early-stage company, engages in the business of licensing technology and intellectual property to operators and businesses in the legal cannabis industry in the United States. The company also provides packaging and labeling, as well as equipment and real property leasing services to various companies. In addition, it offers a plethora of consulting services, including proper business structure and management services in the legal cannabis space serving cultivations, growers, extractors, and dispensaries that operate legally in states that has legal medicinal and/or recreational legislation. The company is headquartered in Centennial, Colorado.
| Metric | 2023 | 2022 | 2021 | 2020 | 2017 | 2016 | 2015 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 390.30K | 587.90K | 322.81K | 85.43K | 0.00 | 0.00 | 0.00 | 537.86K | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 31.96K | 31.96K | 0.29 | 0.52 | 6.05K | 0.00 | 0.00 | 537.86K | 2.17M | 512.75K | 989.66K |
| Gross Profit | 358.34K | 555.94K | 322.81K | 85.43K | -6.05K | 0.00 | 0.00 | 0.00 | -2.17M | -512.75K | -989.66K |
| Gross Profit Ratio | 91.81% | 94.56% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 62.47 | 0.58 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.58 | 120.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 266.50K | 266.50K | 333.85K | 289.70K | 30.59M | 803.14 | 120.58 | 316.07K | 595.32K | 443.77K | 10.87K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -50.02K | -41.66K | -14.23K | -4.62K |
| Operating Expenses | 266.50K | 266.50K | 333.85K | 289.70K | 30.59M | 1.48K | 120.58 | 366.09K | 636.98K | 458.00K | 15.49K |
| Cost & Expenses | 298.46K | 298.46K | 346.89K | 302.74K | 30.59M | 1.48K | 120.58 | 903.95K | 2.80M | 970.74K | 1.01M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 204.48 | 0.00 | 5.69K | 4.75K | 71.42K | 62.99K |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 449.97K | 0.00 | 0.00 | 822.00 | 4.22K | 0.00 | 0.00 |
| Depreciation & Amortization | 31.96K | 31.96K | 13.04K | 13.04K | 6.05K | 1.68 | 120.58 | 5.67K | 750.00 | 0.00 | 154.34K |
| EBITDA | 123.80K | 321.40K | -11.04K | -204.27K | -33.96M | -801.46 | 0.00 | -2.27M | -2.80M | -970.74K | -787.82K |
| EBITDA Ratio | 31.72% | 54.67% | -3.42% | -239.12% | 0.00% | 0.00% | 0.00% | -167.01% | 0.00% | 0.00% | 0.00% |
| Operating Income | 91.84K | 289.44K | -24.08K | -217.31K | -30.59M | -803.14 | -120.58 | -903.95K | -2.80M | -970.74K | -1.01M |
| Operating Income Ratio | 23.53% | 49.23% | -7.46% | -254.38% | 0.00% | 0.00% | 0.00% | -168.07% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -1.00 | -1.00 | -2.00 | -4.00 | -3.82M | -879.03 | 0.00 | -680.09K | 49.24K | 48.91K | 74.10K |
| Income Before Tax | 91.84K | 289.44K | -24.08K | -217.31K | -34.42M | -1.68K | -120.58 | -1.58M | -2.75M | -921.83K | -931.06K |
| Income Before Tax Ratio | 23.53% | 49.23% | -7.46% | -254.39% | 0.00% | 0.00% | 0.00% | -294.51% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.27 | -0.73 | -4.00 | -4.00 | 0.00 | 0.00 | 0.00 | -2.00 | 0.00 | 0.00 | 3.00 |
| Net Income | 91.84K | 289.44K | -24.08K | -217.31K | -34.42M | -1.68K | -120.58 | -1.58M | -2.75M | -921.83K | -931.06K |
| Net Income Ratio | 23.53% | 49.23% | -7.46% | -254.39% | 0.00% | 0.00% | 0.00% | -294.51% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.01 | 0.00 | -0.01 | -1.12 | -0.06 | 0.00 | -6.46K | -13.30K | -17.11K | -33.17K |
| EPS Diluted | 0.00 | 0.01 | 0.00 | -0.01 | -1.12 | -0.06 | 0.00 | -6.46K | -13.06K | -17.11K | -33.17K |
| Weighted Avg Shares Out | 33.81M | 33.81M | 33.81M | 33.16M | 30.63M | 27.53K | 25.75K | 245.35 | 207.15 | 53.88 | 28.07 |
| Weighted Avg Shares Out (Dil) | 33.81M | 33.81M | 33.81M | 33.16M | 30.63M | 27.53K | 25.75K | 245.35 | 210.96 | 53.88 | 28.07 |
Source: https://incomestatements.info
Category: Stock Reports